| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1996;94:102-107.)
© 1996 American Heart Association, Inc.
Articles |
From the Departments of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, and Massachusetts General Hospital, Boston, and the New England Regional Primate Research Center, Southborough, Mass.
Correspondence to Dorothy E. Vatner, MD, New England Regional Primate Research Center, 1 Pine Hill Dr, PO Box 9102, Southborough, MA 01772-9102.
Background It is not clear whether the increase in the myocardial guanylyl nucleotide inhibitory protein (Gi), frequently observed in heart failure, is associated with any functional effects.
Methods and Results Eight sham-operated dogs and 10
dogs were studied with pacing-induced heart failure (240 bpm for 4
to 7 weeks), characterized by reduced (P<.05) left
ventricular dP/dt (from 2926±99 to 1303±126 mm Hg/s). The
muscarinic agonist acetylcholine (10 µg/kg IV) in the presence of
ganglionic blockade reduced left ventricular dP/dt more
(P<.05) in heart failure (-23±2%) than before heart
failure (-8±2%), despite lesser reductions in
arterial pressure.
Gi
2 was increased by 55% in
heart failure. Dose-response curves for carbachol
(10-8 to
10-3 mol/L) inhibition of
isoproterenol-stimulated adenylyl cyclase demonstrated
significantly greater (P<.05) inhibition in heart failure
compared with sham-operated dogs. These changes were associated
with a coordinate increase in muscarinic receptor density, determined
by antagonist binding with 3H-quinuclidinyl
benzilate, in heart failure (153±6.2 fmol/mg protein) compared with
sham-operated dogs (124±7.4 fmol/mg protein). Agonist binding with
carbachol also revealed an increase in total muscarinic receptors in
heart failure without a change in fraction of high- and
low-affinity receptors.
Conclusions These data, in the aggregate, provide physiological and biochemical evidence to support the concept that the coordinate increases in muscarinic receptor number and Gi levels in heart failure are coupled to increased inhibition of adenylyl cyclase activity and an increased inhibition of myocardial contractility.
Key Words: receptors proteins heart failure nervous system, autonomic signal transduction
This article has been cited by other articles:
![]() |
H. Ruan, S. Mitchell, M. Vainoriene, Q. Lou, L.-H. Xie, S. Ren, J. I. Goldhaber, and Y. Wang Gi{alpha}1-Mediated Cardiac Electrophysiological Remodeling and Arrhythmia in Hypertrophic Cardiomyopathy Circulation, August 7, 2007; 116(6): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.J.F. Danson, Y.H. Zhang, C.E. Sears, A.R. Edwards, B. Casadei, and D.J. Paterson Disruption of inhibitory G-proteins mediates a reduction in atrial {beta}-adrenergic signaling by enhancing eNOS expression Cardiovasc Res, September 1, 2005; 67(4): 613 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bibevski and M. E. Dunlap Prevention of diminished parasympathetic control of the heart in experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1780 - H1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Dunlap, S. Bibevski, T. L. Rosenberry, and P. Ernsberger Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1632 - H1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okumura, J.-i. Kawabe, A. Yatani, G. Takagi, M.-C. Lee, C. Hong, J. Liu, I. Takagi, J. Sadoshima, D. E. Vatner, et al. Type 5 Adenylyl Cyclase Disruption Alters Not Only Sympathetic But Also Parasympathetic and Calcium-Mediated Cardiac Regulation Circ. Res., August 22, 2003; 93(4): 364 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain, C. C. Lim, K. Nagata, V. M. Davis, D. S. Milstone, R. Liao, and R. M. Mortensen Targeted inactivation of G{alpha}i does not alter cardiac function or {beta}-adrenergic sensitivity Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H569 - H575. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagata, C. Ye, M. Jain, D. S. Milstone, R. Liao, and R. M. Mortensen G{alpha}i2 but Not G{alpha}i3 Is Required for Muscarinic Inhibition of Contractility and Calcium Currents in Adult Cardiomyocytes Circ. Res., November 10, 2000; 87(10): 903 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du, X.-M. Gao, G. L. Jennings, A. M. Dart, and E. A. Woodcock Preserved ventricular contractility in infarcted mouse heart overexpressing beta 2-adrenergic receptors Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2456 - H2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du, D. J. Autelitano, R. J. Dilley, B. Wang, A. M. Dart, and E. A. Woodcock {beta}2-Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis Circulation, January 4, 2000; 101(1): 71 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Huang, S. Wang, D. Qin, M. Boutjdir, and N. El-Sherif Diminished Basal Phosphorylation Level of Phospholamban in the Postinfarction Remodeled Rat Ventricle : Role of {beta}-Adrenergic Pathway, Gi Protein, Phosphodiesterase, and Phosphatases Circ. Res., October 29, 1999; 85(9): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M Borst, P. Szalai, N. Herzog, W. Kubler, and R. H Strasser Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes Cardiovasc Res, October 1, 1999; 44(1): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bibevski and M. E. Dunlap Ganglionic Mechanisms Contribute to Diminished Vagal Control in Heart Failure Circulation, June 8, 1999; 99(22): 2958 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota, and P. Merlet Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy : An In Vivo PET Study Circulation, November 18, 1997; 96(10): 3416 - 3422. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |